Long-term survival of patients with therapy-related MDS (tMDS) compared with de novo MDS following allogeneic hematopoietic cell transplantation (alloHCT). This is an ASCO Meeting Abstract from the ...
Myelodysplastic syndrome (MDS) is one of the most common haematological malignancies and is associated with increased age and exposure to previous chemotherapy and radiation. It is characterized by ...
The National Eligibility-cum-Entrance Test for entrance to MDS Courses will be held in 86 test centers at 41 cities from November 30 th – December 3 rd, 2016. The examination will be held as a ...
Incorporating Novel Targeted and Immunotherapeutic Agents in the Treatment of B-Cell Lymphomas Myelodysplastic syndrome (MDS) classification currently relies mainly on its morphologic features and ...
Myelodysplastic syndromes (MDS) and autoimmune conditions can overlap, and each may raise the risk of the other. Up to 30% of people with MDS also have an autoimmune disorder. Autoimmune conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results